E-Health Portal for Individualized Treatment Monitoring and Patient Engagement in Oncology Research
NCT ID: NCT03132506
Last Updated: 2025-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
106 participants
OBSERVATIONAL
2017-06-01
2024-07-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comprehensive Patient Reported Outcomes (PRO) Management for Oncology Practice
NCT01108315
Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery
NCT01278537
Relational and Emotional Mechanisms of a Supportive-expressive Group Intervention in Breast Cancer
NCT02934815
Effectiveness of an eHealth Self-management Support Program for Persistent Pain After Breast Cancer Treatment
NCT06308029
Behavioral Activation-Led Activity Engagement for Cancer Empowerment
NCT06796608
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The documentation at baseline should be performed during clinical routine with trained study personnel followed by remote self-reporting to minimize the patient effort. Pepper I will be conducted as sub-protocol of the PRAEGNANT trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
paper-based patient-reported-outcomes
patient-reported-outcomes
Explorative pilot study combining collected data from the PRAEGNANT study on paper-based patient-reported-outcomes with additional collected data on web-based patient-reported-outcomes
on web-based patient-reported-outcomes
patient-reported-outcomes
Explorative pilot study combining collected data from the PRAEGNANT study on paper-based patient-reported-outcomes with additional collected data on web-based patient-reported-outcomes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
patient-reported-outcomes
Explorative pilot study combining collected data from the PRAEGNANT study on paper-based patient-reported-outcomes with additional collected data on web-based patient-reported-outcomes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women aged ≥18 years
* Patients with the diagnosis metastasized breast cancer undergoing any form of systemic therapy
* Patients who are willing and able to sign the informed consent form
* Patients with therapy change
Exclusion Criteria
* Patients who are not able to handle a tablet computer or are unable to write
* Patients who are not able to understand the nature and extent of the trial and the procedures require
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany
UNKNOWN
Department of Gynecology and Obstetrics, University Hospital Heidelberg, Germany
UNKNOWN
Department of Gynecology and Obstetrics, University Hospital Erlangen, Germany
UNKNOWN
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department for Women's Health
Tübingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wallwiener M, Matthies L, Simoes E, Keilmann L, Hartkopf AD, Sokolov AN, Walter CB, Sickenberger N, Wallwiener S, Feisst M, Gass P, Fasching PA, Lux MP, Wallwiener D, Taran FA, Rom J, Schneeweiss A, Graf J, Brucker SY. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial. J Med Internet Res. 2017 Sep 14;19(9):e322. doi: 10.2196/jmir.8210.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pepper
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.